| Form
| Dosage
| Status
| Therapeutic Equivalence
| Active Ingred
| Ref.
| Sponsor
| Document
|
| CREAM; TOPICAL
| 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
| Prescription
| (Reference Drug)
| HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 50218
2004-06-02 Letter |
| OINTMENT; OPHTHALMIC
| 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
| Discontinued
|
| BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 50416
2004-04-05 Label
2004-03-24 Letter |
| OINTMENT; TOPICAL
| 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM
| Prescription
| (Reference Drug)
| BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 50168
2003-12-02 Label
2003-11-28 Letter |
| SOLUTION/DROPS; OTIC
| 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
| Prescription
| AT (Reference Drug)
| HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 50479
1999-08-26 Review |
| SUSPENSION/DROPS; OPHTHALMIC
| 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
| Discontinued
|
| HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 50169
2003-12-02 Letter
2003-12-02 Label |
| SUSPENSION/DROPS; OTIC
| 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
| Prescription
| AT (Reference Drug)
| HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
| hydrocortisone, neomycin, polymyxin B drug combination
| MONARCH PHARMS
| 60613
|